P3 Health Partners Inc, also known as PIII, is a patient-centered, physician-led and population-based healthcare company that aims to improve the health and wellbeing of patients through an integrated healthcare model. Known for its innovative approach within the health industry, P3 Health Partners Inc ensures patients receive not only optimal but also comprehensive care.
Established in 2017 and entity of P3 Health Group, PIII’s operations include delivering primary care services, coordinating care across health providers, employing sophisticated data analytics to derive insights, and managing benefits on behalf of patients. The company serves both private patients and those with Medicare advantage, focusing on prevention and management of chronic conditions.
Headquartered in Las Vegas, Nevada, P3 Health Partners Inc engages carefully chosen professionals renowned for their skills, integrity, and commitment to serving patients. The team consists of a wide range of experts from clinical practitioners, case managers to financial specialists who collaborate to ensure seamless service delivery.
PIII stands firm on preventive and personalized care, putting emphasis on its patient-centric model that aims to promote health, prevent diseases, and manage chronic conditions. This model underscores proactive care to keep patients healthy, rather than just treating them when they become sick.
Besides, the company harnesses big data analytics for precise patient profiling and predictive modeling to identify high-risk individuals, ensure timely interventions, and ultimately, reduce hospitalization rates. This, in turn, helps to lower the cost of care for both the patients and the overall healthcare system.
Moreover, P3 Health Partners Inc utilizes robust health information technology like electronic health records (EHR) to boost care coordination across different health practitioners involved in a patient's care. By focusing on prevention, care, and management, PIII is able to create healthier communities, reduce healthcare costs, and improve patient experience.
Performance-wise, P3 Health Partners Inc has maintained a consistent track record of demonstrating lower hospital admission rates and emergency department visit rates compared to national benchmarks. These impressive outcomes are a testament to PIII's commitment to high-quality healthcare and have garnered it a reputation as a trendsetter in the health sector.
In an industry that's constantly evolving, PIII has its sights set on redefining and improving health outcomes by integrating a patient-centric approach, advanced analytics, and information technology. With a team of dedicated professionals and a patient-first culture, P3 Health Partners Inc embodies the future of healthcare. This forward-thinking healthcare company exemplifies what it means to prioritize both the needs and the well-being of the patients it serves.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
P3 Health Partners Inc. has announced a securities purchase agreement with affiliates of CPF for a private offering of up to $70 million in preferred stock units and warrants. The offering includes Series D-1 19.5% Cumulative Preferred Stock and warrants to acquire Class A Common Stock, with the transaction facilitated due to CPF's related party status under special committee oversight. This multi-tranche deal also involves an extension of CPF's standstill agreement and additional board designation rights.
P3 Health Partners Inc. recently released solid second-quarter results, exceeding analyst revenue forecasts. Despite expectations of increased losses in 2026, analysts have raised their price target to US$18.00, suggesting confidence in the company's long-term intrinsic value. The company's revenue growth is also projected to outpace the wider industry, even with a forecasted slowdown from historical rates.
Hudson Vegas Investment Spv, L sold 50,000 shares of P3 Health Partners (NASDAQ:PIII) stock for $824,000, reducing its stake by over 50%. The sale occurred on August 10th at an average price of $16.48 per share. Despite the sale, P3 Health Partners reported better-than-expected quarterly results, though its stock dipped by 5.5% on Wednesday.
Hudson Vegas Investment SPV, LLC, along with Hudson Vegas Investment Manager, LLC and Daniel Straus, fully divested their direct holdings of P3 Health Partners Inc. (NASDAQ:PIII) Class A Common Stock on August 10, 2026. The sale involved 50,000 shares across three tranches at weighted average prices ranging from $13.38 to $16.86, reducing their direct beneficial ownership to zero. All three entities were identified as 10% owners of P3 Health Partners Inc.
P3 Health Partners (PIII) recently pulled back to $12.38 from an $18.52 post-earnings high, following significant profit-taking. Despite the drop, the company's fundamentals remain strong, with a Q1 profit of $3M compared to a $44.2M loss a year ago, $26M EBITDA, and a strengthened balance sheet due to debt restructuring. The article suggests this pullback offers a potential re-entry point for investors, with key risks including sustaining medical margins, managing membership, cash flow, and future Medicare Advantage rates.